市場調查報告書
商品編碼
1439197
全球基於人工智慧的手術機器人市場評估:按類型、應用、地區、機會、預測(2017-2031)AI-based Surgical Robots Market Assessment, By Type [Services, Instruments and Accessories], Application [General Surgery, Orthopedics, Neurology, Urology, Gynecology, Others], By Region, Opportunities and Forecast, 2017-2031F |
全球基於人工智慧的手術機器人市場規模預計將從 2023 年的 40.3 億美元增至 2031 年的 151.1 億美元,2024-2031 年預測期間複合年增長率為 17.96%。由於手術中越來越多地採用技術,特別是基於人工智慧的提高精度的解決方案,市場正在迅速擴大。手術機器人在微創手術中高度專業化,隨著此類手術需求的增加,將人工智慧整合到手術機器人中是製造商的溫床。用於增強臨床結果的機器學習演算法的進步也推動了市場的顯著成長。基於人工智慧的手術系統可以執行特定任務,例如根據每位患者的手術需求制定方法、指導手術團隊,甚至在手術過程中提供警報、預測和指導。此外,醫療保健提供者和技術組織之間日益加強的合作正在推動對基於人工智慧的手術機器人的需求。投資者對擴大醫療保健產業的吸引力不斷增加,進一步拓寬了未來的前景。
單一手術機器人的成本為數百萬日元,小型醫院和診所無法承擔如此高的成本,限制了目標市場。儘管近年來市場有所擴大,但人工智慧在手術中的信任和接受度仍然是一個問題。各國有關醫療器材與人工智慧融合的法規仍處於制定階段,為廠商開拓市場帶來疑慮。
2023年9月,US Medical Innovations, LLC與Jerome Canady Research Institute for Advanced and Biological Technological Sciences(JCRI-ABTS)合作,以冷大氣壓力等離子體(CAP)進行輻照,這是一種三維非接觸式生物電脈衝電磁場我們宣布推出世界上第一個人工智慧機器人系統Canady Robotic AI Surgical System。該產品預計將於 2024 年初上市。
擴大手術技術的採用
由於技術進步、市場成長和准入條件的改善等多種因素,機器人和數位技術在外科手術中的採用不斷增加。這種增長可以透過人工智慧等技術解決方案的使用增加以及此類解決方案的高通量臨床結果來解釋。基於人工智慧的手術機器人因其提高效率、改善視覺化和微創等優勢而獲得越來越多的認可,這可以進一步縮短康復時間並改善患者的治療效果。隨著技術提供者和醫療設備製造商越來越多地合作,市場參與者正在開發創新產品。
2023年3月,韓國手術機器人製造商Curexo Inc.宣布與微軟公司合作開發以人工智慧為基礎的醫療機器人。Curexo 提供各種手術機器人,並且在過去幾年中增長了數倍。透過此次合作,Curexo將進軍以人工智慧為基礎的手術機器人市場。
機器學習演算法的進展
機器學習為機器人手術帶來了巨大進步,使機器人能夠透過專家演示、反覆試驗或這些方法的組合自主學習手術程序。手術機器人機器學習演算法的進步包括自動縫合、評估手術技能、改進手術機器人材料和建模手術工作流程。此外,機器學習演算法正在增強外科醫生在機器人手術過程中的感知和態勢感知,包括識別解剖區域、提供視覺提示和預測工具軌跡。
2023 年 5 月,Smith+Nephew 開始利用其人工智慧驅動的規劃軟體和資料視覺化平台實現個人化機器人手術。Smith + Nephew 宣布推出 RI.KNEE ROBOTICS v2.0 - 由人工智慧和 RI.INSIGHTS 資料視覺化平台提供支援的個人化規劃,可整合到 CORI 手術系統中。這些補充旨在提高外科醫生的理解,以獲得更好的臨床結果。
本報告研究和分析了全球基於人工智慧的手術機器人市場,提供市場規模和預測、市場動態以及主要參與者的現狀和前景。
Global AI-based surgical robots market is projected to witness a CAGR of 17.96% during the forecast period 2024-2031, growing from USD 4.03 billion in 2023 to USD 15.11 billion in 2031. The AI-based surgical robots market is rapidly expanding due to the growing adoption of technology in surgery, especially AI-based solutions to improve accuracy. Surgical robots are highly specialized in minimally invasive surgeries and with growing demand for such surgeries, AI integration in surgical robots has been a hotbed area for manufacturers. Advancements in machine learning algorithms to enhance clinical outcomes also brought significant growth in the market. AI-based surgical systems can map out approaches to each patient's surgical needs, guide surgical teams, and even perform certain tasks, such as providing alerts, predictions, and guidance during the operation. Furthermore, increasing collaborations between healthcare providers and technological organizations drive the demand for AI-based surgical robots. Rising investors' traction for expanding the healthcare segment further expands the scope for future growth.
The cost of single surgical robots ranges in millions, which limits the target market as small hospitals and clinics cannot afford such high costs. Although the market has expanded in recent years, the trust and acceptance of AI in surgery are still challenging. Regulatory compliances related to medical devices and AI integration are still in the development phase across various nations, which raises concerns for manufacturers to tap the market.
In September 2023, US Medical Innovations, LLC, in collaboration with Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS), announced the launch of Canady Robotic AI Surgical System, which is the world's first AI robotic system that delivers cold atmospheric plasma (CAP), a three-dimensional non-contact bioelectric pulse electromagnetic field. The product is expected to land on the market in early 2024.
Growing Technical Adoption in Surgeries
The adoption of robotic surgery and digital technologies in surgical procedures is on the rise, driven by various factors such as technological advancements, market growth, and increased accessibility. This rise can be explained by growing access to technology solutions like AI and high throughput clinical outcomes from such solutions. Because of the advantages associated with AI-based surgical robots, such as enhanced efficiency, improved visualization, and minimal invasiveness, they gain more traction and further lead to shorter recovery times and better patient outcomes. Market players are developing innovative products, as the collaboration between technology providers and medical device manufacturers is increasing.
In March 2023, South Korean surgical robot maker Curexo Inc. announced a collaboration with Microsoft Corp. to develop AI-based medical robots for surgeries. Curexo offers a variety of surgical robots and has grown severalfold in the past few years. Through this collaboration, Curexo will enter the AI-based surgical robots market.
Advancements in Machine Learning Algorithms
Machine learning has brought significant advancements to robotic surgeries, enabling robots to learn surgical procedures autonomously through expert demonstration, trial-and-error, or a hybrid of these approaches. Some of the advancements in machine learning algorithms for surgical robotics include the automation of suturing, evaluation of surgical skills, improvement of surgical robotic materials, and surgical workflow modeling. Additionally, machine learning algorithms have enhanced a surgeon's perception and situation awareness during robotic surgeries, such as identifying anatomical regions, providing visual cues, and predicting tool trajectories.
In May 2023, Smith+Nephew attempted to personalize robotically enabled surgery with AI-powered planning software and a data visualization platform. Smith+Nephew unveiled RI.KNEE ROBOTICS v2.0 - Personalized Planning powered by AI and RI.INSIGHTS Data Visualization Platform to be incorporated with its CORI Surgical System. These additions aim to improve surgeons' understanding for better clinical outcomes.
Growing Funding for AI Integration in Surgery
The integration of artificial intelligence in surgery is gaining momentum, with increasing funding and potential to revolutionize surgical care. Several startups and small-cap companies are gaining traction from investors due to the promising product pipeline and rapidly expanding market of surgical robots. The growth in funding for AI development in surgical and operating room applications presents strong opportunities for market expansion, despite ongoing regulatory and implementation challenges. Additionally, several grants are being provided to the incubating firms to develop suitable products and services. For instance, in October 2023, Brainomix and Nanoflex Robotics received a grant of EUR 764 thousand under the UK-Switzerland Bilateral. This collaboration is anticipated to develop an AI-assisted magnetic navigation system for robotic surgical tools. Brainomix will contribute to the project through its AI-enabled diagnostic imaging capabilities while Nanoflex Robotics will bring its expertise in precise magnetic navigation technology. Innovate, United Kingdom, and Innosuisse, Switzerland are providing the grant.
Dominance of Instrument and Accessories Segment
The instrument and accessories segment are anticipated to cover the major value share in the market. This dominance can be attributed to increased AI-based surgical robotic equipment development activities, the rising number of robotic surgeries, and the growing acceptance of AI-based robots by surgeons. With the growing demand for surgical precision and minimally invasive surgeries, the installation bases of AI-based surgical robots are anticipated to increase further. Additionally, the multimillion-dollar cost of surgical robots leads to the major share of revenue, further causing the instrument and accessories segment to dominate the market. Hospitals and research centers are conducting trials to install AI-powered surgical robots, which further can be anticipated to expand the market.
In August 2023, The Centre for Artificial Intelligence and Robotics (CAIR), a research center under the Chinese Academy of Sciences, announced the completion of three successful trials on cadavers for the AI-powered surgical robot, MicroNeuro. The success of this trial can be a breakthrough for AI-powered surgeries in Hong Kong.
Orthopedics to Lead the Application Segment
Orthopedics is anticipated to be the central application area of surgical robots. Robotic systems in orthopedic surgery aim to enhance joint arthroplasty by providing support to precisely prepare the bone, restore limb alignment, and ensure the physiological kinematics of the joint. The ability to isolate and rigidly fix bones in known positions makes orthopedic surgery ideally suited for AI-powered robotic systems, leading to more reliable and reproducible outcomes, greater spatial accuracy, and improved range of movement post-procedure. As per an article published by Arthroplasty in December 2023, around 12% of all joint replacement procedures performed in the United States are being done through surgical robots.
In November 2023, Monogram Orthopedics delivered its first surgical robot, mBos robot. mBos robot is an AI-powered orthopedic joint replacement solution that aims to improve orthopedic caregiving by digitalizing manually operated knee replacement surgeries. Monogram Orthopaedics aims to drive the next wave of robotic adoption in orthopedics by ensuring safety, ease of use, streamlined cost, novel implant design, broad clinical functionality, and speed.
North America to be the Dominating Region
North America is anticipated to dominate the AI-based surgical robots market since the region has a well-established healthcare infrastructure, a high demand for minimally invasive surgeries, and a growing focus on AI and robotics training for physicians. The ideal reimbursement scenario in North American countries is promoting using AI-powered surgical robots. Additionally, the region's strong presence of leading market players like Intuitive Surgical, Stryker, and Johnson & Johnson Services, Inc. is again claiming dominance of North America in the market.
Future Market Scenario (2024 - 2031F)
The integration of artificial intelligence in RAS and newer applications for robotic-assisted surgeries are expected to create market opportunities.
The global AI-based surgical robots market is expected to experience steady growth in the coming years, driven by a combination of continuous technological advancements and increasing demand for minimally invasive surgeries.
Instruments and accessories segment is anticipated to be the leading segment in the AI-based surgical robots market due to the growing number of installed bases.
Increasing number of marketed surgical robots for orthopedic applications is causing the orthopedics segment to dominate the market.
Key Players Landscape and Outlook
Accuray Incorporated, Intuitive Surgical, Inc., Medtronic, plc, and Zimmer Biomet Holdings, Inc. are some of the key players in the global AI-based surgical robots market. Several small market players and startups have promising product pipelines that are anticipated to help expand the market. Regulatory approvals and collaborations between tech and medical device providers bring innovative products to the market. Mergers, acquisitions, and other market tactics also help with market growth.
In September 2023, Asensus Surgical, Inc. announced a collaboration with NVIDIA to enable AI integration in its Intelligent Surgical Unit (ISU). Asensus's ISU is made with NVIDIA's real-time augmented intelligent features, such as digital tags, 3D measurement, and enhanced camera control, for a better surgeon experience.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.